Sign In
Buy CVSI
$0.0272
-0.0025 (-8.48%)
At Close: Jun 03, 2026
CV Sciences, Inc. Applauds the California Legislature for Passage of AB 45
01:01pm, Thursday, 07'th Oct 2021
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cann
CV Sciences, Inc. (CVSI) Reports Q2 Loss, Tops Revenue Estimates
08:50pm, Thursday, 12'th Aug 2021
CV Sciences, Inc. (CVSI) delivered earnings and revenue surprises of 0.00% and 0.24%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2021 Results - Earnings Call Transcript
07:17pm, Thursday, 12'th Aug 2021
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2021 Results - Earnings Call Transcript
CV Sciences, Inc. Reports Second Quarter 2021 Financial Results
04:05pm, Thursday, 12'th Aug 2021
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cann
CV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award
08:00am, Tuesday, 27'th Jul 2021
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cann
CBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences
01:30pm, Thursday, 22'nd Jul 2021
This week, CV Sciences (OTCQB:CVSI) released the results of a preclinical study that suggests that CBD can reduce nicotine withdrawal symptoms in smokeless tobacco users. The study, conducted in coll
Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences
12:10pm, Friday, 18'th Jun 2021
Cantor Fitzgerald's Pablo Zuanic provided updated ratings and estimates on several stocks from the cannabis and CBD sector, those being – MedMen Enterprises (OTCQF: MMNFF), Jushi Holdings (OTC
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2021 Results - Earnings Call Transcript
09:10pm, Thursday, 13'th May 2021
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2021 Results - Earnings Call Transcript
Will CV Sciences, Inc. (CVSI) Report Negative Q1 Earnings? What You Should Know
03:47pm, Friday, 07'th May 2021
CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (C
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q4 2020 Results - Earnings Call Transcript
08:13pm, Thursday, 18'th Mar 2021
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q4 2020 Results - Earnings Call Transcript
CV Sciences, Inc. (CVSI) Reports Q4 Loss, Lags Revenue Estimates
06:33pm, Thursday, 18'th Mar 2021
CV Sciences, Inc. (CVSI) delivered earnings and revenue surprises of -350.00% and -22.52%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock
CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results
04:05pm, Thursday, 18'th Mar 2021
SAN DIEGO, March 18, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp can
A Preview Of CV Sciences's Earnings
10:39am, Wednesday, 17'th Mar 2021
CV Sciences (OTC:CVSI) will be releasing its next round of earnings this Thursday, March 18. For all of the relevant information, here is your guide for Thursday's Q4 earnings announcement.
Will CV Sciences, Inc. (CVSI) Report Negative Q4 Earnings? What You Should Know
01:38pm, Monday, 08'th Mar 2021
CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
